Control Pseudarthrosis Risks with Spine Fusion Stimulation
Research analyzing why pseudarthrosis occurs has identified risk factors that can compromise good fusion outcomes. An estimated 76% of patients who underwent a spinal fusion procedure in 2009 possessed one or more risk factors1, including:
*Medicare criteria; may also apply to other payers.
Consider your high risk patients and review the clinical trial data
Studies show that bone growth stimulation is a proven therapy to lower the risk for pseudarthrosis in at-risk patients. Nearly 100,000 spine fusion stimulators were prescribed by spine surgeons in 2009, which is an increase of 6.6% over the prior year.1
In an era when expenses for products to enhance fusion such as bone morphogenetic protein (BMP) are closely scrutinized, Orthofix’s Spinal-Stim and Cervical-Stim bone growth stimulators provide surgeons and their at-risk patients with a solid solution to achieving fusion that is cost-effective and guaranteed. Obtain the Cost Savings Analysis.
Todd McCall, MD received no remuneration for his testimonial video commentaries.
Jonathan P. Partington, MD received no remuneration for his testimonial video commentaries.